FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Amlodipine Besylate and Olmesartan Medoxomil Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc. (New 03/11/2019)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
5 mg/20 mg tablets (NDCs 0093-7027-56 and 0093-7027-98) 03/11/2019 This product discontinuation is a business related decision.
5 mg/40 mg tablets (NDCs 0093-7028-56 and 0093-7028-98) 03/11/2019 This product discontinuation is a business related decision.
10 mg/20 mg tablets (NDCs 0093-7029-56 and 0093-7029-98) 03/11/2019 This product discontinuation is a business related decision.
10 mg/20 mg tablets (NDCs 0093-7030-56 and 0093-7030-98) 03/11/2019 This product discontinuation is a business related decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English